Biotech Values

[exwannabe]

Re: PPHM, that's not quite the real problem,

That they are hyping these single arm trials is one thing.

But my problem with them is that they have been in this state for at least 3 years.

This should be simple, if the drug was really working this well they would have started a sound P2 trial to get the ball rolling.

The failure to start such trial is due to what?

Obvious answer, the data just is not what it seams.